Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Video-assisted thoracic surgery and pneumothorax.

Paliouras D, Barbetakis N, Lazaridis G, Baka S, Mpoukovinas I, Karavasilis V, Kioumis I, Pitsiou G, Papaiwannou A, Karavergou A, Lampaki S, Katsikogiannis N, Mpakas A, Tsakiridis K, Korantzis I, Fassiadis N, Zarogoulidis K, Zarogoulidis P.

J Thorac Dis. 2015 Feb;7(Suppl 1):S56-61. doi: 10.3978/j.issn.2072-1439.2015.01.35. Review.

2.

Barotrauma and pneumothorax.

Ioannidis G, Lazaridis G, Baka S, Mpoukovinas I, Karavasilis V, Lampaki S, Kioumis I, Pitsiou G, Papaiwannou A, Karavergou A, Katsikogiannis N, Sarika E, Tsakiridis K, Korantzis I, Zarogoulidis K, Zarogoulidis P.

J Thorac Dis. 2015 Feb;7(Suppl 1):S38-43. doi: 10.3978/j.issn.2072-1439.2015.01.31. Review.

3.

Physiology of the pleural space.

Charalampidis C, Youroukou A, Lazaridis G, Baka S, Mpoukovinas I, Karavasilis V, Kioumis I, Pitsiou G, Papaiwannou A, Karavergou A, Tsakiridis K, Katsikogiannis N, Sarika E, Kapanidis K, Sakkas L, Korantzis I, Lampaki S, Zarogoulidis K, Zarogoulidis P.

J Thorac Dis. 2015 Feb;7(Suppl 1):S33-7. doi: 10.3978/j.issn.2072-1439.2014.12.48. Review.

4.

Pleura space anatomy.

Charalampidis C, Youroukou A, Lazaridis G, Baka S, Mpoukovinas I, Karavasilis V, Kioumis I, Pitsiou G, Papaiwannou A, Karavergou A, Tsakiridis K, Katsikogiannis N, Sarika E, Kapanidis K, Sakkas L, Korantzis I, Lampaki S, Zarogoulidis K, Zarogoulidis P.

J Thorac Dis. 2015 Feb;7(Suppl 1):S27-32. doi: 10.3978/j.issn.2072-1439.2015.01.48. Review.

5.

Thoracocentesis: from bench to bed.

Kalifatidis A, Lazaridis G, Baka S, Mpoukovinas I, Karavasilis V, Kioumis I, Pitsiou G, Papaiwannou A, Karavergou A, Tsakiridis K, Katsikogiannis N, Sarika E, Kapanidis K, Sakkas L, Korantzis I, Lampaki S, Zarogoulidis K, Zarogoulidis P.

J Thorac Dis. 2015 Feb;7(Suppl 1):S1-4. doi: 10.3978/j.issn.2072-1439.2014.12.45.

6.

Use of proteins as biomarkers and their role in carcinogenesis.

Zarogoulidis P, Tsakiridis K, Karapantzou C, Lampaki S, Kioumis I, Pitsiou G, Papaiwannou A, Hohenforst-Schmidt W, Huang H, Kesisis G, Karapantzos I, Chlapoutakis S, Korantzis I, Mpakas A, Karavasilis V, Mpoukovinas I, Li Q, Zarogoulidis K.

J Cancer. 2015 Jan 1;6(1):9-18. doi: 10.7150/jca.10560. eCollection 2015. Review.

7.

Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel.

Korantzis I, Kalogeras KT, Papaxoinis G, Kotoula V, Koutras A, Soupos N, Papakostas P, Dionysopoulos D, Samantas E, Christodoulou C, Linardou H, Pectasides D, Fountzilas G.

Anticancer Res. 2012 Oct;32(10):4569-80.

PMID:
23060588
8.

Polyuria due to central diabetes insipidus presenting as an early manifestation of acute myeloid leukemia.

Loukidis K, Papadakis E, Anagnostou N, Kiriklidou P, Gatsa E, Karagianni A, Patinakis P, Tsakiris D, Kioumi A, Korantzis I.

Clin Adv Hematol Oncol. 2012 Jun;10(6):399-400. No abstract available.

PMID:
22895244
9.

Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).

Kotoula V, Krikelis D, Karavasilis V, Koletsa T, Eleftheraki AG, Televantou D, Christodoulou C, Dimoudis S, Korantzis I, Pectasides D, Syrigos KN, Kosmidis PA, Fountzilas G.

BMC Cancer. 2012 Aug 6;12:342. doi: 10.1186/1471-2407-12-342.

10.

A case of a primary cutaneous plasmacytoma presenting in adolescence.

Koletsa T, Patsatsi A, Kostopoulos I, Kartsios C, Korantzis I, Sotiriadis D.

Am J Dermatopathol. 2012 Jul;34(5):537-40. doi: 10.1097/DAD.0b013e318245955d.

PMID:
22421294
11.

Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study.

Pectasides D, Papaxoinis G, Kotoula V, Fountzilas H, Korantzis I, Koutras A, Dimopoulos AM, Papakostas P, Aravantinos G, Varthalitis I, Kosmidis P, Skarlos D, Bournakis E, Bafaloukos D, Kalofonos HP, Kalogeras KT, Fountzilas G.

Oncol Rep. 2012 Jan;27(1):216-24. doi: 10.3892/or.2011.1504. Epub 2011 Oct 13.

PMID:
22025320
12.

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.

Papadimitriou CA, Papakostas P, Karina M, Malettou L, Dimopoulos MA, Pentheroudakis G, Samantas E, Bamias A, Miliaras D, Basdanis G, Xiros N, Klouvas G, Bafaloukos D, Kafiri G, Papaspirou I, Pectasides D, Karanikiotis C, Economopoulos T, Efstratiou I, Korantzis I, Pisanidis N, Makatsoris T, Matsiakou F, Aravantinos G, Kalofonos HP, Fountzilas G.

BMC Med. 2011 Jan 31;9:10. doi: 10.1186/1741-7015-9-10.

13.

Insulin resistance is associated with at least threefold increased risk for prothrombotic state in severely obese youngsters.

Galli-Tsinopoulou A, Kyrgios I, Maggana I, Giannopoulou EZ, Kotanidou EP, Stylianou C, Papadakis E, Korantzis I, Varlamis G.

Eur J Pediatr. 2011 Jul;170(7):879-86. doi: 10.1007/s00431-010-1370-9. Epub 2010 Dec 8.

PMID:
21140274
14.

Isolated Splenic Mycobacterial Disease: A Cause of Persistent Fever in a Hairy Cell Leukemia Patient.

Papadopoulos V, Kartsios C, Spyrou A, Loukidis K, Miyakis S, Pervana S, Makridis C, Kioumi A, Korantzis I.

Case Rep Gastroenterol. 2010 Sep 11;4(3):330-334.

15.

Deletion of 5q as a rare abnormality in chronic lymphocytic leukemia.

Karakosta M, Tsakiridou A, Korantzis I, Manola KN.

Cancer Genet Cytogenet. 2010 Jul 15;200(2):175-9. doi: 10.1016/j.cancergencyto.2010.04.002.

PMID:
20620603
16.

Low protein Z levels, but not the intron F G79A polymorphism, are associated with unexplained pregnancy loss.

Topalidou M, Effraimidou S, Farmakiotis D, Papadakis E, Papaioannou G, Korantzis I, Garipidou V.

Thromb Res. 2009 May;124(1):24-7. doi: 10.1016/j.thromres.2008.09.017. Epub 2008 Nov 20.

PMID:
19026439
17.

Delayed malignant melanoma recurrence simulating primary ovarian cancer: case report.

Boutis A, Valeri R, Korantzis I, Valoukas D, Andronikidis I, Andreadis C.

World J Surg Oncol. 2008 Nov 20;6:124. doi: 10.1186/1477-7819-6-124.

18.

TLR4 single nucleotide polymorphisms and thrombosis risk in patients with myeloproliferative disorders.

Speletas M, Liadaki K, Kalala F, Daiou C, Katodritou E, Mandala E, Korantzis I, Ritis K, Zintzaras E, Germenis AE.

Thromb Res. 2008;122(1):27-32. Epub 2007 Nov 14. No abstract available.

PMID:
17999935
19.

Pneumonia caused by Candida krusei and Candida glabrata in a patient with chronic myeloid leukemia receiving imatinib mesylate treatment.

Speletas M, Vyzantiadis TA, Kalala F, Plastiras D, Kokoviadou K, Antoniadis A, Korantzis I.

Med Mycol. 2008 May;46(3):259-63.

PMID:
17885950
20.

Correlations of JAK2-V617F mutation with clinical and laboratory findings in patients with myeloproliferative disorders.

Speletas M, Katodritou E, Daiou C, Mandala E, Papadakis E, Kioumi A, Ritis K, Korantzis I.

Leuk Res. 2007 Aug;31(8):1053-62. Epub 2006 Oct 12.

PMID:
17045648
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk